Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DR26FM3M1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,245
Award facts
- Contract value 100% obligated
- $11,244.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $11,244.66. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ozempic is a diabetes medication used primarily for glycemic control in patients with type 2 diabetes and is a critical pharmaceutical commodity for military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This primary contract vehicle enables AmerisourceBergen to serve as a global pharmaceutical supplier to support military healthcare programs, providing a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive bidding positions it as a key vendor in DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FM3M1?
SPE2DR26FM3M1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FM3M1 worth?
The government has obligated $11,245 on SPE2DR26FM3M1.
Is contract SPE2DR26FM3M1 an order under another contract?
Yes. SPE2DR26FM3M1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM3M1 competed?
The extent of competition for SPE2DR26FM3M1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award